ConductScience.org, home

Paper33822285

Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.

Girón-Ortega JA and 5 others. Eur J Clin Microbiol Infect Dis, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis. Papers, record 33822285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33822285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
PubMed
Journal
Eur J Clin Microbiol Infect Dis
PubMed
Year
2021
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Girón-Ortega JAJosé-Antonio
2Márquez-Coello MMercedes
3Gutiérrez-Saborido DDaniel
4Arizcorreta AAna
5Cuesta-Sancho SSara
6Girón-González JAJosé-Antoniohttps://orcid.org/0000-0002-7482-5828

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
CD4-Positive T-LymphocytesMajor topic
CD8-Positive T-LymphocytesMajor topic
CoinfectionMajor topic
HIV InfectionsMajor topic
HepacivirusMajor topic
Lipopolysaccharide ReceptorsMajor topic
Liver CirrhosisMajor topic
CD4 Lymphocyte Count
Female
Hepatitis C
Humans
Male
Middle Aged
Sustained Virologic Response

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No PI-0076-2017
Secretaría General de Investigación, Desarrollo e Innovación en Salud, Junta de Andalucía, Iniciativa Territorial Integrada 2014-2020 para la provincia de Cádiz, Spain. Co-financed by FEDER (Fondo Europeo de Desarrollo Regional).
PubMed

Source PubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120479633Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.AIDS2010https://conductscience.org/library/papers/20479633PubMed
228734831Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.Gastroenterology2017https://conductscience.org/library/papers/28734831PubMed
321252259Plasma levels of soluble CD14 independently predict mortality in HIV infection.J Infect Dis2011https://conductscience.org/library/papers/21252259PubMed
424831517
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
PLoS Pathog2014https://conductscience.org/library/papers/24831517PubMed
522610932Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.Clin Infect Dis2012https://conductscience.org/library/papers/22610932PubMed
615034063CD14 is an acute-phase protein.J Immunol2004https://conductscience.org/library/papers/15034063PubMed
725775475Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.PLoS One2015https://conductscience.org/library/papers/25775475PubMed
828109003Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.Hepatology2017https://conductscience.org/library/papers/28109003PubMed
923429381Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.Clin Infect Dis2013https://conductscience.org/library/papers/23429381PubMed
1027371888CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR.J Clin Virol2016https://conductscience.org/library/papers/27371888PubMed
1129986086Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.J Infect Dis2018https://conductscience.org/library/papers/29986086PubMed
1216080095Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.Clin Infect Dis2005https://conductscience.org/library/papers/16080095PubMed
1326819512Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.World J Gastroenterol2016https://conductscience.org/library/papers/26819512PubMed
1424717910Revised surveillance case definition for HIV infection--United States, 2014.MMWR Recomm Rep2014https://conductscience.org/library/papers/24717910PubMed
1526424550CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.Lancet HIV2015https://conductscience.org/library/papers/26424550PubMed
1621505312Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.AIDS2011https://conductscience.org/library/papers/21505312PubMed
1717879910The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.Clin Infect Dis2007https://conductscience.org/library/papers/17879910PubMed
1824010646Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.J Viral Hepat2013https://conductscience.org/library/papers/24010646PubMed
197903975Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.J Infect Dis1994https://conductscience.org/library/papers/7903975PubMed
207585150Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study.Nat Med1995https://conductscience.org/library/papers/7585150PubMed

See all 34 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40938627Role of immune cell subsets in liver fibrosis through single-cell RNA sequencing and array.Cancer Biomark2025https://conductscience.org/library/papers/40938627PubMed
40397618Hepatic Markers and Immunological Trajectories in a Cohort of Patients with HIV and Hepatitis C Virus Coinfection Treated with Direct-Acting Antivirals.AIDS Res Hum Retroviruses2025https://conductscience.org/library/papers/40397618PubMed
36777459Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection.HIV AIDS (Auckl)2023https://conductscience.org/library/papers/36777459PubMed
35062255Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.Viruses2021https://conductscience.org/library/papers/35062255PubMed
35047528The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients.Front Med (Lausanne)2021https://conductscience.org/library/papers/35047528PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33822285

GET https://conductscience.org/api/papers/v1/33822285/references?page=2